S.Amdt. 1546

Ms. Warren, along with Mr. Markey, submitted this amendment to the concurrent resolution establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.

What It Aims to Change or Add

• Creates a point of order in the Senate against considering any bill, joint resolution, motion, amendment, amendment between the Houses, or conference report.

• Stops the Senate from moving forward with legislation until the 15 percent cap on the use of National Institutes of Health funding for indirect costs is lifted for institutions that conduct research or clinical trials on rare diseases, chronic diseases, pediatric diseases, cancer, Alzheimer's disease, diabetes, or cystic fibrosis.

• Requires an affirmative vote of three-fifths of the Members, duly chosen and sworn, to waive or suspend this rule in the Senate.

• Requires an affirmative vote of three-fifths of the Members, duly chosen and sworn, to sustain an appeal of the ruling of the Chair on a point of order raised under this rule.